Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Alzheimer's Disease

Interventions

BIOLOGICAL

PF-04360365

10 mg/kg, single dose administered intravenously

DRUG

Placebo

Trial Locations (3)

Pfizer Investigational Site, St Louis

Pfizer Investigational Site, Glendale

Pfizer Investigational Site, Stockholm